These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19318690)

  • 1. Insulin pump therapy: guidelines for successful outcomes.
    Scheiner G; Sobel RJ; Smith DE; Pick AJ; Kruger D; King J; Green K
    Diabetes Educ; 2009; 35 Suppl 2():29S-41S; quiz 28S, 42S-43S. PubMed ID: 19318690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump therapy in childhood diabetes mellitus: guidelines for use.
    Tamborlane WV; Fredrickson LP; Ahern JH
    Treat Endocrinol; 2003; 2(1):11-21. PubMed ID: 15871551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators.
    Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin pump therapy for type 2 diabetes.
    Kirk SE
    Curr Diab Rep; 2003 Oct; 3(5):373-7. PubMed ID: 12975026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bolus calculator: a review of four "smart" insulin pumps.
    Zisser H; Robinson L; Bevier W; Dassau E; Ellingsen C; Doyle FJ; Jovanovic L
    Diabetes Technol Ther; 2008 Dec; 10(6):441-4. PubMed ID: 19049372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
    Kesavadev J; Jain SM; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of insulin pump therapy in children with type 1 diabetes.
    Abdullah N; Pesterfield C; Elleri D; Dunger DB
    Arch Dis Child Educ Pract Ed; 2014 Dec; 99(6):214-20. PubMed ID: 25125555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy.
    Rubin RR; Borgman SK; Sulik BT
    Diabetes Educ; 2011; 37 Suppl 1():5S-18S; quiz 19S-20S. PubMed ID: 21217102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical monitoring of miniaturized insulin infusion pumps for increased therapeutical security in the treatment of type-I diabetics.
    Tschöpe D; Schumacher M; Gries A
    Med Prog Technol; 1987; 13(1):47-52. PubMed ID: 3441243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
    Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.